By Jeremiah Velasquez, FNP-BC, AGACNP-BC | Founder, Steel City HRT & Weight Loss | Board-Certified Family & Acute Care Nurse Practitioner | NPI: 1841894003

Direct Answer: Estradiol — the primary estrogen in men — is the dominant regulator of the hypothalamic-pituitary feedback axis that controls testosterone production. When aromatase inhibitors are given to healthy men, LH and FSH rise significantly. Adding estradiol back reverses this effect; adding non-aromatizable androgens like DHT does nothing. The feedback signal the brain uses to regulate testosterone is estradiol, not testosterone itself.

Somewhere along the way, the testosterone optimization conversation got rewritten — and the chapter on estrogen got left out entirely.

If you're a man in Sheridan, Wyoming who's ever been told your estrogen is running too high and been handed an aromatase inhibitor to bring it down, you received a protocol built on an incomplete picture. Not malicious. Just shaped by a healthcare system that had fifteen minutes, a reference range, and a reflex — and never enough time to explain what it was actually doing to your endocrine axis.

Here is what didn't make it into that conversation: your brain does not regulate testosterone by measuring testosterone. Not directly. The signal controlling your hypothalamus and pituitary — the one that tells your body whether to ramp production up or let it fall — runs almost entirely through estradiol. The same hormone being suppressed with protocols that have become routine without becoming correct.

That is not a fringe position. It has been demonstrated in controlled human studies with clean mechanistic data. And when that feedback loop is disrupted by unmonitored estrogen suppression, the consequences do not stay in the endocrine system. They migrate into your metabolism, your lipid panel, your insulin sensitivity, and your body composition.

So what is actually happening inside your hormone system — and why has the standard conversation been so slow to catch up?

What's Actually Wrong With How Men's Estrogen Levels Are Being Managed?

Your provider isn't wrong to track estradiol. The system is wrong for how it taught providers to respond when they see it.

For decades, estrogen in men has been framed as testosterone's antagonist — the hormone responsible for gynecomastia, mood instability, low libido, and water retention. And so the reflex became reflexive: estrogen up, suppress it. The aromatase inhibitor goes in, the problem is solved, nobody looks back. But that reflex was never built on a full understanding of what estradiol does in the male body, and men throughout Wyoming — where getting to a specialty endocrinologist means losing a full day to travel — are the ones absorbing the clinical cost of an incomplete protocol.

Estradiol is the aromatized form of testosterone, produced when the enzyme aromatase converts circulating androgens in peripheral tissues throughout the body. The aromatase enzyme is encoded by the CYP19A1 gene, and approximately 80–90% of a man's daily estradiol production occurs outside the testes — in fat tissue, muscle, and skin — with only 10–20% originating directly from testicular production.

When aromatase inhibitors are used without confirmed deficiency, without accurate measurement, and without follow-up monitoring — which is how they are frequently used in the TRT context, where their application is entirely off-label with no FDA approval and limited long-term safety data — three compounding failures tend to occur. One: the HPG axis loses its primary negative feedback signal, causing LH and FSH to dysregulate in ways that undermine the very testosterone production the protocol claimed to protect. Two: insulin sensitivity declines, with estrogen deficiency strongly associated with increased fasting glucose and insulin resistance based on human aromatase deficiency case data in the endocrinology literature. Three: the lipid profile shifts in an atherogenic direction — higher total cholesterol, higher LDL, lower HDL — worsening cardiovascular risk. The treatment creates the metabolic syndrome it was supposed to prevent.

That is not a theoretical concern. That is the documented clinical record.

Key takeaway: Unmonitored aromatase inhibitor use in men is associated with HPG axis dysregulation, insulin resistance, atherogenic lipid shifts, and increased visceral fat — consequences of estrogen deficiency, not estrogen excess.

How Does Estradiol Actually Control Testosterone Production — and What Happens When You Block It?

Here is what most people do not know: testosterone does not regulate its own production. Not directly. It has to be converted first — and everything downstream depends on that conversion.

The hypothalamic-pituitary-gonadal (HPG) axis is the hormonal command structure that governs testosterone output. The hypothalamus releases GnRH, which signals the pituitary to release LH and FSH, which drives Leydig cells in the testes to produce testosterone. Negative feedback — the mechanism that keeps this axis calibrated — depends on circulating sex steroids telling the hypothalamus and pituitary that production is sufficient.

What is counterintuitive, and what changes everything about the standard TRT conversation, is which hormone carries that feedback signal. Testosterone exerts its inhibitory effect on the HPG axis almost entirely after it is aromatized to estradiol. Estradiol then binds estrogen receptor alpha (ERα) at both the hypothalamic and pituitary levels, completing the feedback loop that tells the system to reduce GnRH and gonadotropin output.

The evidence for this is mechanistically clean. Administering aromatase inhibitors to healthy men causes LH and FSH to rise significantly — a direct signal that negative feedback has been lost. When estradiol is added back, that elevation reverses. When non-aromatizable androgens like dihydrotestosterone (DHT) are substituted instead, nothing changes. According to findings synthesized from human aromatase deficiency cases and GnRH-deficient men studied in the endocrinology literature, circulating estradiol — not locally produced estrogen within the hypothalamus and pituitary — is the main inhibitor of LH and FSH secretion.

Think of estradiol as the thermostat on the wall. Testosterone is the heat it is regulating. Removing the thermostat does not make the system run better. It makes the system run blind.

Block estradiol, and you are not suppressing one hormone in isolation. You are severing the primary feedback cable that keeps the entire axis calibrated. LH and FSH become erratic. Testosterone output dysregulates. And in the metabolic and cardiovascular systems downstream, the body begins showing the signs of a hormone environment that no longer knows what normal looks like.

For Wyoming men working through what clinical testosterone and hormone optimization actually involves, this mechanism is not academic context. It is the foundation of whether a protocol is building the system up or quietly tearing it apart.

Key takeaway: Estradiol — not testosterone — is the dominant negative feedback signal at the hypothalamic and pituitary levels; aromatase inhibitors block this signal, dysregulate the HPG axis, and trigger measurable metabolic consequences independent of testosterone levels.

What Does Accurate Hormone Optimization Actually Look Like for Wyoming Men?

You know something is off. That is not in your head — it is in your bloodwork, and the right test was never ordered to show it.

Real hormone optimization does not start with a prescription. It starts with an accurate measurement of the full axis — including estradiol measured via liquid chromatography-tandem mass spectrometry (LC-MS/MS), the analytical gold standard for quantifying estrogen at the concentrations typical in men. LC-MS/MS is the validated method for accurately diagnosing estrogen deficiency or monitoring hormone therapy in men; standard immunoassay platforms lack the sensitivity to reliably measure estradiol at male-range concentrations, according to diagnostic guidance from the endocrinology field. Without it, you are making clinical decisions off a reading that may be systematically off. That is not optimization. That is guesswork with a lab report attached.

Here is what the process actually looks like for men taking this seriously. Starting with a comprehensive panel — total testosterone, free testosterone, estradiol by LC-MS/MS, LH, FSH, SHBG, and a metabolic workup — followed by a provider consult that interprets those results in the context of symptoms and clinical history, and ending with an individualized plan that treats the full axis rather than just the number that looked easiest to suppress.

There is one clinical distinction worth naming directly, because most men in Wyoming never hear it in a standard appointment: hot flushes in hypogonadal men are caused by estrogen deficiency, not testosterone deficiency alone. If vasomotor symptoms have been part of your experience and the treatment focused exclusively on testosterone, estradiol was not on the radar — and the underlying feedback disruption was left in place.

Men in Cheyenne and throughout Wyoming do not need to schedule a clinic visit to get this evaluation done. Telehealth handles the full workup — no time off work, no waiting rooms, no half-day commute to access a provider who understands the whole system.

Two options exist at this point. Keep following a protocol that suppresses the hormone your brain depends on to regulate its own testosterone output. Or find a provider who measures the right things from the beginning.

Key takeaway: Accurate hormone optimization requires LC-MS/MS estradiol measurement, full-axis lab evaluation, and clinical interpretation that accounts for the feedback dynamics standard immunoassay protocols cannot capture.

Why Are Wyoming Men Choosing Steel City HRT & Weight Loss for Full-Axis Hormone Optimization?

I have been on both sides of that table. I have been the patient handed a protocol that treated a lab value without understanding the system behind it. I have also been the provider stretched within a structure that made it nearly impossible to slow down and do this work correctly. That dual experience is why Steel City HRT & Weight Loss exists and why it is built the way it is.

Steel City HRT & Weight Loss is LegitScript-certified — the same independent certification standard held by major pharmacy chains — which means our clinical protocols and sourcing practices have been externally verified. We are fully licensed in Wyoming and operate 100% via telehealth. There is no clinic to find. There is no commute. There are no waiting rooms between you and clinical-grade care.

As a board-certified nurse practitioner, Jeremiah Velasquez, FNP-BC, AGACNP-BC, built Steel City's hormone protocols around a single non-negotiable: we measure the whole axis. That includes estradiol by LC-MS/MS — because optimization requires understanding how the system actually works, not just which number on a standard lab report is easiest to address.

Programs include TRT and comprehensive hormone optimization for men, with ongoing monitoring built into the clinical process. All medications are sourced exclusively from licensed 503a compounding pharmacies. Patient communication runs through a HIPAA-secure app — no unanswered questions, no gaps between visits, no vanishing after the prescription goes out.

We do not just measure testosterone. We measure everything that tells the story.

Ready to Get Started? Wyoming Men Can See a Provider This Week.

Whether you are in Sheridan or Cheyenne, full-axis hormone care does not require leaving the state or rearranging your week. Steel City HRT & Weight Loss is entirely telehealth — the lab order, the consult, and the optimization plan come to you.

No waiting rooms. No paperwork bottlenecks. No fifteen-minute appointment trying to cover a question that deserves a full conversation.

Keep following a protocol that suppresses the hormone your brain uses to run its entire endocrine feedback system — or get the complete picture and start actually optimizing.

Labs, consult, optimization. That easy.

It all starts at steelcity-trt.com.

Frequently Asked Questions

Q: Does estrogen actually control testosterone levels in men?

A: Yes — estradiol, the primary estrogen in men, is the dominant regulator of the hypothalamic-pituitary feedback axis that controls testosterone production. Testosterone exerts its inhibitory effect on gonadotropin secretion primarily after it is aromatized to estradiol. Without adequate circulating estradiol, the feedback loop that keeps testosterone output calibrated becomes dysregulated.

Q: What are the side effects of aromatase inhibitors in men?

A: Aromatase inhibitor use in men is associated with elevated LH and FSH due to lost negative feedback, along with insulin resistance, an atherogenic lipid profile (higher LDL and total cholesterol, lower HDL), and increased visceral fat accumulation. These effects reflect the consequences of estrogen deficiency. Their use in TRT or otherwise healthy men is entirely off-label, with limited long-term safety data.

Q: What is LC-MS/MS estradiol testing, and why does it matter for men on TRT?

A: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the validated gold standard for measuring estradiol in men. Standard immunoassays lack the sensitivity to reliably capture estradiol at male-range concentrations, making them prone to inaccurate readings. LC-MS/MS provides the precision required to accurately diagnose estrogen deficiency, monitor hormone therapy, and guide real optimization decisions.

Q: Can I get full hormone axis testing in Wyoming without visiting a clinic?

A: Yes. Steel City HRT & Weight Loss is a fully telehealth practice licensed in Wyoming. Lab orders, provider consultations, and ongoing monitoring are managed remotely through a HIPAA-secure platform. No in-person clinic visit is required — men in Sheridan, Cheyenne, and across Wyoming access care without leaving home or taking time off work.

Q: Is Steel City HRT & Weight Loss available in Wyoming?

A: Yes. Steel City HRT & Weight Loss is licensed to practice in Wyoming and operates as a fully telehealth clinic. Steel City is LegitScript-certified and provides TRT and comprehensive hormone optimization for men, with estradiol measured via LC-MS/MS as part of the standard clinical evaluation.

Q: Why do hypogonadal men get hot flushes, and what does that mean hormonally?

A: Hot flushes in hypogonadal men are driven by estrogen deficiency, not testosterone deficiency alone. The vasomotor symptoms associated with low hormone states in men are primarily linked to estradiol decline. Treating testosterone without evaluating and addressing estradiol may fail to resolve these symptoms and leaves the underlying HPG axis disruption unaddressed.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed provider before beginning any hormone or weight loss therapy. Jeremiah Velasquez, FNP-BC, AGACNP-BC, is a licensed nurse practitioner. Steel City HRT & Weight Loss is a LegitScript-certified telehealth clinic.